Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,207,118
+$54,830 QoQ
Shares Held
4,753
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,816
of 4,664 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Purpose Unlimited Inc. holds $21,432,780 across 11 Drug Manufacturers - General names. JNJ ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
100,180 | $12,873,129 | |
| 2 | AZN |
Astrazeneca PLC
|
15,503 | $2,939,678 | |
| 3 | LLY |
ELI LILLY & Co
|
1,253 | $1,502,884 | |
| 4 | AMGN |
Amgen Inc
|
3,970 | $1,437,616 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
4,753 | $1,207,118 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,683 | $970,669 | |
| 7 | ABBV |
AbbVie Inc.
|
754 | $189,736 | |
| 8 | NVO |
Novo Nordisk A S
|
3,739 | $179,247 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,207,118 | 4,753 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,152,288 | 4,714 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $131,413 | 635 | Shares | Sole | 2026-03-20 | |
| No filing history on record for this holder in this stock. | ||||||